Syon Capital’s Zimmer Biomet ZBH Stock Holding History

Syon Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,978	Closed	-$337K	–	791
2025 Q1	$337K	Buy	2,978 +694	+30%	+$74.2K	0.03%	391
2024 Q4	$241K	Buy	+2,284	New	+$245K	0.02%	464
2024 Q3	–	Sell	-1,888	Closed	-$205K	–	487
2024 Q2	$205K	Buy	1,888 +51	+3%	+$6.01K	0.02%	422
2024 Q1	$242K	Sell	1,837 -1,523	-45%	-$190K	0.02%	399
2023 Q4	$409K	Buy	+3,360	New	+$375K	0.02%	444

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Syon Capital's ZBH Position: Q2 2025 in Review

Syon Capital sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,978 shares — an estimated $337K sold.

Syon Capital first reported a position in ZBH in Q4 2023 and held it in 5 quarters. The position peaked at $409K in Q4 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Syon Capital reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
Syon Capital sold 2,978 Zimmer Biomet shares in Q2 2025, an estimated $337K.
Syon Capital first reported a position in Zimmer Biomet in Q4 2023 and held it in 5 quarters.
Syon Capital's Zimmer Biomet position peaked at $409K in Q4 2023.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Syon Capital's 13F filing for Q2 2025, filed 14 Aug 2025.